© 2025 Organized & Managed By Quote Hub
Welcome
Dear Colleagues,
On behalf of the Kuwait Hematology Association, it is my pleasure to welcome you to the Myeloma Symposium on Tuesday, 11 November 2025 at Ahmadi Hospital. This focused meeting brings together a multidisciplinary faculty to share practical, practice‑changing updates spanning hematopathology, biochemical and laboratory work‑up, state‑of‑the‑art imaging, frontline and relapsed/refractory management, and the nephrology perspective.
Our aim is to translate advances into everyday care—clear diagnostic pathways, evidence‑based treatment sequencing, and proactive strategies to prevent and manage complications—always centred on patient outcomes. Sessions are concise, case‑anchored, and designed for discussion.
Dr. Ahmad Alhuraiji Chairperson · Hematology Consultant Target Audience
Hematologists & medical oncologists
Pathologists & hematopathologists
Clinical biochemists / laboratory medicine
Radiologists (WBLD‑CT, MRI spine, PET‑CT)
Nephrologists (myeloma kidney, AKI & CKD)
Clinical pharmacists & infusion teams
Trainees/residents & specialist nurses
Allied health professionals involved in myeloma care
Agenda
| Time | Topic | Speaker |
|---|---|---|
| 11:30 – 12:00 | Registration & Welcome Coffee | |
| 12:00 – 12:10 | Opening Remarks | Dr. Ahmad Al‑Huriji · Dr. May Alrushood |
| Session 1: Diagnostic Approach | ||
| 12:10 – 12:30 | Hematopathology in Myeloma Diagnosis | Dr. Maryam Alfili |
| 12:30 – 12:50 | Biochemistry and Laboratory Work‑up | Dr. Mohammad Albader |
| 12:50 – 01:10 | Imaging in Myeloma: Diagnostic and Monitoring Roles | Dr. May Alrushood |
| Session 2: Management and Perspectives | ||
| 01:10 – 02:10 | Myeloma Management Guidelines and Therapeutic Updates | Dr. Ahmad Al‑Huriji |
| 02:10 – 02:30 | Nephrology Perspective in Myeloma | Dr. Monther Alsharekh |
| Session 3: Interactive Segment | ||
| 02:30 – 02:50 | Q&A | All Faculty |
| 02:50 – 03:00 | Closing Remarks | |
| 03:00 | Light Refreshments & Networking | |
Session 1: Diagnostic Approach
11:30 – 12:00
Registration & Welcome Coffee
12:00 – 12:10
Opening Remarks
Dr. Ahmad Al‑Huriji · Dr. May Alrushood
12:10 – 12:30
Hematopathology in Myeloma Diagnosis
Dr. Dina Elkady
12:30 – 12:50
Biochemistry and Laboratory Work‑up
Dr. Thanaa Qutob
12:50 – 01:10
Imaging in Myeloma: Diagnostic and Monitoring Roles
Dr. Wael Meftah
Session 2: Management and Perspectives
01:10 – 02:10
Myeloma Management Guidelines and Therapeutic Updates
Dr. Ahmad Al‑Huriji
02:10 – 02:30
Nephrology Perspective in Myeloma
Dr. Monther Alsharekh
02:30 – 02:40
Q&A
All Faculty
02:40 – 02:45
Closing Remarks
02:45
Lunch & Networking
Registration
Collaboration
Platinum Sponsor
Gold Sponsors
Silver Sponsor
Venue
Ahmadi Hospital, Kuwait — Tuesday, 11 November 2025.
Welcome
Dear Colleagues,
On behalf of the Kuwait Hematology Association, it is my pleasure to welcome you to the Myeloma Symposium on Tuesday, 11 November 2025 at Ahmadi Hospital. This focused meeting brings together a multidisciplinary faculty to share practical, practice‑changing updates spanning hematopathology, biochemical and laboratory work‑up, state‑of‑the‑art imaging, frontline and relapsed/refractory management, and the nephrology perspective.
Our aim is to translate advances into everyday care—clear diagnostic pathways, evidence‑based treatment sequencing, and proactive strategies to prevent and manage complications—always centred on patient outcomes. Sessions are concise, case‑anchored, and designed for discussion.
Dr. Ahmad Alhuraiji
Chairperson · Hematology Consultant
Target Audience
Hematologists & medical oncologists
Pathologists & hematopathologists
Clinical biochemists / laboratory medicine
Radiologists (WBLD‑CT, MRI spine, PET‑CT)
Nephrologists (myeloma kidney, AKI & CKD)
Clinical pharmacists & infusion teams
Trainees/residents & specialist nurses
Allied health professionals involved in myeloma care
Agenda
| Time | Topic | Speaker |
|---|---|---|
| 11:30 – 12:00 | Registration & Welcome Coffee | |
| 12:00 – 12:10 | Opening Remarks | Dr. Ahmad Al‑Huriji · Dr. May Alrushood |
| Session 1: Diagnostic Approach | ||
| 12:10 – 12:30 | Hematopathology in Myeloma Diagnosis | Dr. Maryam Alfili |
| 12:30 – 12:50 | Biochemistry and Laboratory Work‑up | Dr. Mohammad Albader |
| 12:50 – 01:10 | Imaging in Myeloma: Diagnostic and Monitoring Roles | Dr. May Alrushood |
| Session 2: Management and Perspectives | ||
| 01:10 – 02:10 | Myeloma Management Guidelines and Therapeutic Updates | Dr. Ahmad Al‑Huriji |
| 02:10 – 02:30 | Nephrology Perspective in Myeloma | Dr. Munther Alsharekh |
| Session 3: Interactive Segment | ||
| 02:30 – 02:50 | Q&A | All Faculty |
| 02:50 – 03:00 | Closing Remarks | |
| 03:00 | Light Refreshments & Networking | |
Session 1: Diagnostic Approach
11:30 – 12:00
Registration & Welcome Coffee
12:00 – 12:10
Opening Remarks
Dr. Ahmad Al‑Huriji · Dr. May Alrushood
12:10 – 12:30
Hematopathology in Myeloma Diagnosis
Dr. Dina Elkady
12:30 – 12:50
Biochemistry and Laboratory Work‑up
Dr. Thanaa Qutob
12:50 – 01:10
Imaging in Myeloma: Diagnostic and Monitoring Roles
Dr. Wael Meftah
Session 2: Management and Perspectives
01:10 – 02:10
Myeloma Management Guidelines and Therapeutic Updates
Dr. Ahmad Al‑Huriji
02:10 – 02:30
Nephrology Perspective in Myeloma
Dr. Munther Alsharekh
Session 3: Interactive Segment
02:30 – 02:50
Q&A
All Faculty
02:50 – 03:00
Closing Remarks
03:00
Light Refreshments & Networking
Registration
Collaboration
Sponsored By
Venue
Ahmadi Hospital, Kuwait — Tuesday, 11 November 2025.